Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05086185 · ClinicalTrials.gov registry record
Effect of Viscous Fiber on Postprandial Kalemic Response in Hemodialysis Patients
A clinical trial, sponsored by University of Nevada, Reno.
- Completed
- Registry status
- 7
- Enrollment target
NCT05086185: Completed study, sponsored by University of Nevada, Reno.
NCT05086185 is a clinical trial that has completed, run by University of Nevada, Reno. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05086185 has completed, sponsored by University of Nevada, Reno.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
High blood potassium levels (hyperkalemia) is a major problem for people with kidney failure undergoing hemodialysis treatment. In order to reduce the risk of hyperkalemia, people with kidney failure are advised to limit or avoid high-potassium foods. However, high-potassium foods comprise many healthy food choices, including commonly consumed fruits and vegetables that are key sources of dietary fiber, and other important nutrients. Risk of hyperkalemia from dietary potassium intake is most notable in the first few hours after a meal when ingested potassium enters the bloodstream. In general, dietary potassium is very well absorbed. However, dietary fiber has been shown to increase the proportion of dietary potassium that is excreted in stool. Based on these findings, it has been proposed that fiber may help to lower the risk of hyperkalemia in people with kidney disease. It remains unclear whether dietary fiber increases potassium excretion in stool by reducing the absorption of dietary potassium, or by drawing body potassium into the bowels by increasing stool bulk. The distinction may be important, as reducing potassium absorption would be expected to be of greater benefit in preventing hyperkalemia caused by eating high-potassium foods. In this study, the investigators will assess whether a fiber supplement can reduce the effect of dietary potassium from orange juice on blood potassium levels in people with kidney disease undergoing maintenance hemodialysis treatment.
Primary Outcome
The kalemic response to study treatments will be assessed based on peak change in plasma potassium concentrations compared to pre-treatment.
Interventions
- DIAGNOSTIC_TEST Kalemic Response to Orange Juice
- DIETARY_SUPPLEMENT Kalemic Response to Orange Juice with Fiber
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2023-10-05 |
What the finished NCT05086185 record still lists
NCT05086185 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Kalemic Response to Orange Juice is the first listed.
NCT05086185 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05086185 about?
NCT05086185 is a clinical study titled "Effect of Viscous Fiber on Postprandial Kalemic Response in Hemodialysis Patients". High blood potassium levels (hyperkalemia) is a major problem for people with kidney failure undergoing hemodialysis treatment. In order to reduce the risk of hyperkalemia, people with kidney failure are advised to limit or avoid high-potassium foods. However, high-potassium foods comprise many heal...
What is the current status of trial NCT05086185?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2021-06-29. Estimated completion is 2023-10-05.
What interventions are being tested in trial NCT05086185?
The interventions under investigation include: Kalemic Response to Orange Juice (DIAGNOSTIC_TEST), Kalemic Response to Orange Juice with Fiber (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05086185?
This trial is sponsored by University of Nevada, Reno, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI